10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001651308-19-000111`
Period End Date	20190930
Filing Date	20191112
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	beigene2019q310-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 76 Cash Flow Statement 107 Stockholders Equity 49 Comprehensive Income 28

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$856.15M	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$643.49M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.27M	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	784.44M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.56M	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	776.26M	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	78.44M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$1.07B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$375.77M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$55.91M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$41.06M	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	-	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	$8.61M	USD	Point-in-time
Inventories	`InventoryNet`	$37.51M	USD	Point-in-time
Inventories	`InventoryNet`	$16.24M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$81.94M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$95.94M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.94B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.44B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$30.40M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$52.75M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$226.50M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$157.06M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$45.06M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$71.04M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$75.34M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$6.18M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.17M	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$42.15M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$29.54M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$64.85M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$53.67M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$445.52M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$305.84M	USD	Point-in-time
Total assets	`Assets`	$2.25B	USD	Point-in-time
Total assets	`Assets`	$1.88B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$113.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$112.28M	USD	Point-in-time
Accrued expenses and other payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$100.41M	USD	Point-in-time
Accrued expenses and other payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$133.02M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$18.14M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$5.89M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$9.06M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.67M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$8.68M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$700.00K	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$8.73M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$265.73M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$104.23M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$40.78M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$148.89M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$150.76M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	-	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$9.84M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.85M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.76M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$10.68M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.14M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$36.58M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$38.93M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$249.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$321.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$496.04M	USD	Point-in-time
Total liabilities	`Liabilities`	$586.83M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 784,440,698 and 776,263,184 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$77.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 784,440,698 and 776,263,184 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$78.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.86B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.74B	USD	Point-in-time
Accumulated other comprehensive (loss)/income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.53M	USD	Point-in-time
Accumulated other comprehensive (loss)/income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-14.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.57B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.74B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.28B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.76M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.45M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.23B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.25B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$1.88B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$371.32M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$139.55M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$54.20M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$50.14M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$19.51M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$53.21M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$8.71M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$20.11M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$236.97M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$421.54M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$147.59M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$644.08M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$122.89M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$48.82M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$244.90M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$105.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$331.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$563.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$994.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$188.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$362.41M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$943.17M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$205.30M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$564.51M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-312.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-151.10M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-571.85M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-424.96M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$4.55M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$8.00M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$9.57M	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$2.21M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$1.58M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-1.82M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-967.00K	USD	3 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$2.39M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-311.88M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-144.96M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-563.25M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-414.57M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-7.25M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-472.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-569.00K	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-3.22M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.30M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.12M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-461.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.81M	USD	3 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-307.36M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-144.03M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-560.57M	USD	3 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-405.51M	USD	3 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	3 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.58	USD	3 Qtrs
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	777.94M	shares	3 Qtrs
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	781.48M	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	703.48M	shares	3 Qtrs
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	739.79M	shares	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-2.53	USD	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-5.11	USD	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-7.49	USD	3 Qtrs
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-9.37	USD	3 Qtrs
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	59.84M	shares	3 Qtrs
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	54.11M	shares	3 Qtrs
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	56.91M	shares	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstanding`	60.11M	shares	1 Quarter

Cash Flow Statement 107 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$7.03M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$11.13M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$61.17M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$95.81M	USD	3 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.00M	USD	3 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$49.00M	USD	3 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$5.48M	USD	3 Qtrs
Non-cash interest expense	`InterestExpenseOperatingActivities`	$5.96M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-8.80M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-13.33M	USD	3 Qtrs
Realized gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$4.51M	USD	3 Qtrs
Realized gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$822.00K	USD	3 Qtrs
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	$-4.44M	USD	3 Qtrs
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	$-3.70M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$7.94M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$14.86M	USD	3 Qtrs
Unbilled receivable	`IncreaseDecreaseInContractWithCustomerAsset`	$-8.61M	USD	3 Qtrs
Unbilled receivable	`IncreaseDecreaseInContractWithCustomerAsset`	$-11.43M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$8.77M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$21.27M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$34.30M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$14.27M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	$4.30M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$15.31M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$8.50M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.58M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.15M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$33.49M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$26.28M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.17M	USD	3 Qtrs
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-7.61M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-5.68M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-27.98M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$12.91M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.50M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$2.07M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-353.82M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-483.09M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.03M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.15M	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$221.00K	USD	3 Qtrs
Prepayment of assets acquisition	`PaymentForAssetAcquisition`	-	USD	3 Qtrs
Prepayment of assets acquisition	`PaymentForAssetAcquisition`	$7.95M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$2.12B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$850.83M	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.55B	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.33B	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$49.00M	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$10.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-850.86M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$578.05M	USD	3 Qtrs
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$758.00M	USD	3 Qtrs
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	-	USD	3 Qtrs
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	$414.00K	USD	3 Qtrs
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Proceeds from HK IPO and global follow-on public offering	`ProceedsFromCommonStockIssuanceAndInitialPublicOffering`	$875.37M	USD	3 Qtrs
Proceeds from HK IPO and global follow-on public offering	`ProceedsFromCommonStockIssuanceAndInitialPublicOffering`	-	USD	3 Qtrs
Payment of HK IPO and global follow-on public offering costs	`PaymentsOfInitialPublicOfferingCostAndStockIssuanceCost`	-	USD	3 Qtrs
Payment of HK IPO and global follow-on public offering costs	`PaymentsOfInitialPublicOfferingCostAndStockIssuanceCost`	$5.66M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$4.00M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Proceeds from long-term bank loans	`ProceedsFromLongTermLinesOfCredit`	$67.49M	USD	3 Qtrs
Proceeds from long-term bank loans	`ProceedsFromLongTermLinesOfCredit`	$42.31M	USD	3 Qtrs
Repayment of long-term bank loan	`RepaymentsOfLongTermLinesOfCredit`	$8.39M	USD	3 Qtrs
Repayment of long-term bank loan	`RepaymentsOfLongTermLinesOfCredit`	$8.74M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$20.39M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$20.86M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$83.48M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.68B	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-5.86M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-18.34M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$160.11M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$471.19M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$900.82M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$710.80M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$900.82M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$710.80M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$856.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$643.49M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.27M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.56M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$30.40M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$52.75M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$12.15M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$8.95M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$3.33M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.55M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$29.25M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$12.02M	USD	3 Qtrs
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	$-2.29M	USD	3 Qtrs
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	-	USD	3 Qtrs

Stockholders Equity 49 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.23B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	78.44M	shares	Point-in-time
Contributions from shareholders	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$4.00M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.37M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$10.28M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.74M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.27M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.31M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.27M	USD	1 Quarter
Issuance of ordinary shares in connection with follow-on public offering	`StockIssuedDuringPeriodValueNewIssues`	$757.59M	USD	1 Quarter
Issuance of ordinary shares in connection with follow-on public offering	`StockIssuedDuringPeriodValueNewIssues`	$869.71M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.39M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.64M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$17.40M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$36.82M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$25.13M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$32.60M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.44M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-6.44M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-14.93M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-3.86M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$601.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$2.75M	USD	1 Quarter
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	78.44M	shares	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.23B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.98B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-157.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-144.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-85.95M	USD	1 Quarter
Net loss	`ProfitLoss`	$-562.68M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-407.32M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-308.66M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-17.25M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.91M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.22M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-13.67M	USD	1 Quarter
Unrealized holding gain (loss), net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.26M	USD	1 Quarter
Unrealized holding gain (loss), net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$354.00K	USD	1 Quarter
Unrealized holding gain (loss), net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.40M	USD	3 Qtrs
Unrealized holding gain (loss), net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$326.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-148.35M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-323.59M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-407.83M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-579.61M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.81M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-2.69M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-486.00K	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.63M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-576.92M	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-406.02M	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-321.96M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-147.87M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.